Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00135447 · ClinicalTrials.gov registry record
A Study of Prevalence of the I50L Mutation When ATV Treated Patients Fail the Regimen
A clinical trial, sponsored by Bristol-Myers Squibb.
- Completed
- Registry status
- 5,000
- Enrollment target
NCT00135447 is a clinical trial that has completed, run by Bristol-Myers Squibb. The registered enrollment target is 5,000 participants.
The verdict
NCT00135447 has completed, sponsored by Bristol-Myers Squibb.
- COMPLETED
- Registry status
- 5,000 participants
- Enrollment target
Study Summary
The purpose of this study is to find out the frequency of the I50L substitution among patients experiencing treatment failure on an atazanavir-containing regimen.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5,000 participants |
| Start Date | 2004-09 |
| Est. Completion | 2009-09 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00135447
The ClinicalTrials.gov registry entry for NCT00135447 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 5,000 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Bristol-Myers Squibb, which has 1,025 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00135447 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00135447 about?
NCT00135447 is a clinical study titled "A Study of Prevalence of the I50L Mutation When ATV Treated Patients Fail the Regimen". The purpose of this study is to find out the frequency of the I50L substitution among patients experiencing treatment failure on an atazanavir-containing regimen.
What is the current status of trial NCT00135447?
This trial is currently completed. The enrollment target is 5,000 participants. The study started on 2004-09. Estimated completion is 2009-09.
Who is sponsoring clinical trial NCT00135447?
This trial is sponsored by Bristol-Myers Squibb, which has 1,025 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.